Press Releases for SVA

Press Releases
PicksThatMove.com Announces Investment Opinion on American International Group Inc., JA Solar Holdings Company Ltd., Sinovac Biotech Ltd., Fresh Harvest Products Inc. and Royal Bank of Canada
PicksThatMove.Com Announces Investment Opinion EXBX, YRCW, SNDK, GNPG and SVA
Halter USX China Index Up 10.59% for Third Quarter 2009
China to unveil swine flu vaccine
Sinovac Reports Unaudited Second Quarter 2009 Financial Results
Sinovac Reports Top-Line Preliminary Results of H1N1 Vaccine Clinical Trials
Sinovac to Host Conference Call to Report 2009 Second Quarter Financial Results
Revised: Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
Sinovac Provides Update on Clinical Trial for H1N1 Vaccine Trials
Sinovac Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1)
Sinovac Adjourns 2008 Annual General Meeting
Halter USX China Index Up 40.88% for Second Quarter 2009
Sinovac Receives Revised Approvals for Panflu
BenchmarkJournal.Com (Complimentary) Analyst Review for ACM, UA, TRE, SVA, AI and ALK
Sinovac Receives China's First Influenza A (H1N1) Vaccine Order
Sinovac Schedules 2008 Annual General Meeting
Sinovac Begins the Production of Influenza A (H1N1) Vaccine
China's Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation
Sinovac Reports Unaudited First Quarter 2009 Financial Results
Sinovac to Host Conference Call to Report First Quarter 2009 Financial Results
Sinovac Biotech Ltd. Files Annual Report on Form 20-F
Sinovac Initiates Preparatory Activities for Swine Flu Vaccine
Sinovac Receives RMB 87 Million Purchase Order for Healive from China's Ministry of Public Health
/C O R R E C T I O N -- Sinovac Biotech Ltd./
Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables
Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results
Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2008 Financial Results
Halter USX China Index Announces First Quarter 2009 Results and Adds New Constituents - Mar 31 2009 8:21PM
Sinovac Biotech Co. Ltd., Sinovac's Beijing Subsidiary, Obtains High-Tech Enterprise Status
Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility
Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine
Sinovac Announces that Government Investigation Rules Out Healive's Role in Child's Death
Sinovac Named to Zhongguancun's Top 20 Most Influential Brands
Sinovac Announces Share Repurchase Program
Sinovac Releases Statement on Healive Vaccine Suspension
Sinovac Reports Third Quarter 2008 Unaudited Financial Results
Sinovac to Host Conference Call to Report Third Quarter 2008 Financial Results
Sinovac Named to Deloitte Technology Fast 50 China
Sinovac to Participate in Two Upcoming Investor Conferences
Sinovac's Credit Rating Upgraded to AAZ, Second Highest Rating
Sinovac Initiates Development of Vaccine Against Hand, Foot, and Mouth Disease
Sinovac Biotech Increases Ownership Position in its Operating Subsidiary Sinovac Beijing
Sinovac Biotech Holds 2007 Annual General Meeting
Sinovac to Present at the 2008 UBS Global Life Sciences Conference
Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine
Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
Sinovac Adjourns Annual General Meeting
Sinovac to Present at the Susquehanna Financial Group's Second Annual Beijing Management Summit Conference
Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results
Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
Sinovac to Host Conference Call to Report Second Quarter 2008 Financial Results
Revised Analyst Reports for Sinovac Biotech Ltd., Petro Resources Corporation, Allied Nevada Gold Corp., And Inverness Medical Innovations Inc.
Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine
Sinovac Receives Healive(R) and Bilive(R) Purchase Orders from Provincial CDCs for Earthquake Disaster Areas
Sinovac Delivers 80,000 Doses of Bilive to Gansu Earthquake Disaster Area
Dutton Associates Announces Investment Opinion: Sinovac Biotech Strong Speculative Buy Rating In Update Coverage By Dutton Associates - Jun 10 2008 10:45AM
Sinovac Receives RMB 20 Million Purchase Order for Healive from China's Ministry of Health to Vaccinate Earthquake Victims
Sinovac Provides Support to China's Ministry of Health to Aid Earthquake Victims - May 27 2008 1:00AM
Sinovac Reports First Quarter 2008 Unaudited Financial Results - May 27 2008 12:55AM
Sinovac to Host Conference Call to Report First Quarter 2008 Financial Results - May 27 2008 12:53AM
Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008 - May 27 2008 1:38AM
Dutton Associates Announces Investment Opinion: Sinovac Biotech Strong Speculative Buy Rating In Update Coverage By Dutton Associates - Jun 2 2008 5:07AM
Sinovac Biotech Holds Annual General Meeting
Sinovac Receives China State Food and Drug Administration (SFDA) Approval for Pandemic Influenza H5N1 Vaccine